RESTRICTED · INTERNAL ONLY · NOT FOR EXTERNAL CIRCULATION
VANTAGE-OTC LABS · STUDIO
VANTAGE-OTC Studio
Studio · Sponsor pitches · Reckitt master agreement
← Back to Studio
⚑ PITCH #2 IN SEQUENCE · BAYER IS #1 · this pitch sends 48h after Bayer (15 Jun)
Bayer pitch (#1) → Phase 1 doctrine →
Vantage-OTC Labs · sponsor pitch · draft v1
CRITICAL PATH · LOI BY 13 AUG · 12 WEEKS
2026-05-22 · cold approach
Sponsor outreach · master agreement

Reckitt master agreement.
Four brands. Two waves. One conversation.

The first and highest-leverage sponsor conversation in the Vantage-OTC Labs program. Reckitt sits on the OTC self-care category brands that anchor Wave 1 (Strepsils · Lemsip · Nurofen Cold & Flu) and the Wave 2 ride-along (Gaviscon). One master agreement covers four sponsorships across two waves. Sales-cycle clock starts the day the intro email goes out.

12 wks
Sales cycle to first LOI
May 22 → Aug 13 target
4 brands
In scope · 1 conversation
Strepsils · Lemsip · Nurofen C&F · Gaviscon
€90k+
Annual value · floor
5 module-season slots
3 markets
UK · NL · CH
Phase 1 footprint
01Part 1 · the 1-pager · attach to the intro email

The commercial brief Reckitt's category team reads first.

One page. Six sections. Designed for the 90-second scan a category director gives to inbound sponsorship proposals before deciding whether to take the discovery call.

For Reckitt Health · Self-Care Category · From Vantage-OTC Labs

Master sponsorship · Vantage-OTC Labs Seasonal Health Intelligence™

Four brands · two launch waves · 27 October 2026 go-live · category-leadership position in a market segment Reckitt currently leads commercially but does not measure.
01 · WHAT IT IS

The Bloomberg Terminal for European OTC seasonal demand.

Vantage-OTC Labs is launching the first commercial intelligence platform that ties biological seasonal signals (pollen · UV · ILI · DST · resolution-wave calendar) to OTC category demand multipliers, refreshed daily, across NL · UK · CH for Phase 1. Built on the Vantage OTC platform — already serving 32 European markets, 255 OTC molecules, and 18 regulatory registers since Q4 2024.

Seven modules launch across four waves between October 2026 and May 2027. Each module is sponsorable by the OTC brand whose category it drives. The "Powered by Vantage-OTC Labs" producer mark stays; the "Presented by [Sponsor]" position is yours to own.

02 · WHY THIS IS FOR RECKITT

You already lead these categories commercially. Now lead them intelligently.

Reckitt's Self-Care portfolio sits across four of the seven seasonal demand-multiplier categories the platform tracks. No other single sponsor has this much overlap with the Vantage-OTC Labs product map. We're offering you first-mover sponsorship across the entire winter respiratory category plus the festive GI moment — before competitors know the inventory exists.

The Cough/Cold/Flu category brief (attached) shows the math: Reckitt brands account for an estimated ~50% of OTC sales velocity across Strepsils + Lemsip + Nurofen C&F in Phase 1 markets during winter peak weeks. Vantage-OTC Labs surfaces this demand 4-12 weeks ahead to pharmacies, drugstores, and retailers.

03 · THE FOUR SPONSORSHIP SLOTS

What's in the master agreement.

BRAND
WIDGET · WAVE
MARKETS
VALUE
Strepsils
Flu & Cough Watch™ · Wave 1 · Oct 26
UK · NL · CH
€18k × 3 mkts
Lemsip
Flu & Cough Watch™ · Wave 1 · Oct 26
UK + IE
€18k × 1 mkt
Nurofen Cold & Flu
Flu & Cough Watch™ adjunct · Wave 1
UK · NL
incl. master
Gaviscon
Holiday Stomach Watch™ · Wave 2 · Dec 26
UK · NL · CH
€18k × 3 mkts

List price: €18,000 per module per market per season. Master-agreement structure offers volume terms across 4 brands + 2 waves; right-of-first-refusal on Phase 2 markets (FR · IT · ES · BE · DE · Nordics) when those open in Q2 2027.

04 · WHAT YOU GET

Tier 03 · OTC brand sponsorship.

For each (brand · market · season) slot: "Presented by [Brand]" position on the live widget, in the desktop application, and in all embed instances across partner retailer sites (Boots · Kruidvat · Coop Vitality). Per-market sponsor exclusivity for the duration. Quarterly engagement report (page views · embed loads · retailer adoption · regional concentration). Right of first refusal on the same slot in the following season.

What you do not get: any influence over the data, the multiplier model, or the editorial framing. The "Powered by Vantage-OTC Labs" mark stays on every instance and the data is the same number for every customer, sponsored or not.

05 · WHAT WE NEED NEXT

A 30-minute discovery call before June 15.

The October launch sponsor cycle closes in mid-August. To activate Strepsils + Lemsip + Nurofen C&F by October 27, we need:

· 30-min discovery call before 15 June 2026
· Diagnostic call with brand team(s) before 15 July 2026
· LOI before 13 August 2026
· Active sponsor on widget by 27 October 2026 launch

06 · WHY WE'RE MOVING NOW

October is the natural launch window — and the only one available before March 2027.

Wave 1 launches at the start of the European flu season (ECDC ILI surveillance shows winter ramp begins late October), in time for UK Stoptober's last week. Missing October means waiting until March 2027 for the next equivalent commercial moment (hayfever season + Bayer Claritin sponsorship window). The sales-cycle constraint is the only thing on the program's critical path that cannot be parallelized.

NEXT STEP
30-minute discovery call. Bring whoever owns category-marketing strategy for Self-Care. We'll walk the platform, the math, and the master-agreement terms. Available any day before 15 June. Reply to this email with two times that work — we'll book.
Harm Jan Schuurman · Founder · Vantage-OTC Labs
harmjan.schuurman@vantage-otc.com · vantage-otc.com
02Part 2 · intro email · ready to copy-paste

The short email that opens the door · 110 words.

First-touch outreach should be short, specific, and respect the recipient's time. The 1-pager attached as PDF (or as a link to this studio page if you want sponsor reviewers to land behind Cloudflare Access first — preferred for confidentiality).

ATTACHMENT STRATEGY
Best practice: attach this 1-pager as PDF (export from the studio page · Cmd+P → Save as PDF). Plus the Cough/Cold/Flu category brief (do the same). Two attachments, ~600 words total — short enough to read in one sitting, substantial enough to take seriously.
03Part 3 · cold-approach playbook · finding the right Reckitt contact

Four ways into the conversation · ordered by effectiveness.

No existing Reckitt relationship means cold outreach — but cold doesn't mean random. Reckitt's category-marketing org structure is well-mapped. The right title + right office reaches the right inbox 60-70% of the time.

PATH 1 · WARM INTRO

2nd-degree LinkedIn connection

Always tried first. Search LinkedIn for "Reckitt" employees with mutual connections. Best mutual-connection types: ex-AstraZeneca · ex-GSK CH · IQVIA UK · AESGP attendees · former NielsenIQ analysts.

The intro request to your shared connection should be short: 2 sentences, link to this 1-pager, ask if they'd be willing to forward (not introduce — lower friction).

Hit rate: ~50-70% if mutual connection forwards. Time: 1-2 weeks to first response.
PATH 2 · COLD LINKEDIN INMAIL

Direct InMail to category director

LinkedIn Premium InMail to the named role. Personalized 3-sentence opener referencing a Reckitt-specific brand action (e.g., recent Strepsils packaging change · Lemsip campaign · Nurofen geo-expansion). Then link to studio page.

Avoid generic "interested in partnership?" Tone — Reckitt people delete those by reflex. Lead with the specific brand fact + the specific moment (October launch).

Hit rate: ~15-25% response. Time: 3-5 days to response (if at all).
PATH 3 · INDUSTRY EVENT

AESGP / NHS / OTC Summit hallway

Reckitt always sends senior people to AESGP annual (Brussels) · NACDS Annual (US, less relevant) · OTC Summit · Self-Care Innovation Awards. If any of these are coming up before August, attend, find the Reckitt person, hand them the 1-pager directly.

Next AESGP-related event: AESGP Annual Meeting 2026 · check the calendar. Brussels-based · 2 days · sponsor section + networking lunches.

Hit rate: ~40% conversation in-person · ~60% follow-up call. Time: depends on event timing.
PATH 4 · COLD EMAIL + FOLLOW-UP CADENCE

3-touch sequence over 2 weeks

If Paths 1-3 don't open the door fast enough, fall back to direct email with the 1-pager. Use the address pattern firstname.lastname@reckitt.com (Reckitt's standard format). Validate via Hunter.io or by checking LinkedIn profile.

Cadence: Day 1 (full intro + 1-pager). Day 6 (short bump · "wanted to make sure this didn't get lost"). Day 14 (final touch · "happy to revisit in Q3 if timing's off · here's the deadline math").

Hit rate: ~10-15% after 3 touches. Time: 2-3 weeks.

Target roles · who at Reckitt to find

Reckitt re-organized its Health business in 2023 — the "Reckitt Self-Care" or "Reckitt Health" unit is the right team. Avoid the "Hygiene" side (Dettol · Air Wick) — they own different categories.

ROLE
WHY THEM
SEARCH
PRIORITY
Category Director · Self-Care Respiratory
Highest leverage. Owns Strepsils + Lemsip + Nurofen Cold & Flu commercial strategy. Single conversation can authorize the master agreement.
P1 · primary
VP / Director · Brand Marketing · Strepsils EU
Single-brand owner. Easier to engage than category director · narrower decision but high autonomy for their brand.
P1 · alt
Head of Insights · Self-Care / OTC
Owns the data/intelligence stack. Most likely to genuinely understand the value of Vantage-OTC Labs immediately. May not have signing authority but champions internally.
P2 · champion
Senior Brand Manager · Lemsip UK
UK-specific anchor. Lemsip is the most UK-concentrated brand — UK Brand Manager is decisive for that single slot.
P2 · UK-only
Procurement · Marketing Services
Last-resort path. Procurement gates external services contracts. Reaching here without category alignment first usually means delays — but if all else fails, this is the formal sponsorship-procurement track.
P3 · avoid first

Office locations · Reckitt HQ Slough (UK) · Reckitt Health Brussels (EU) · Reckitt CH Wallisellen (CH). Strepsils brand team is Brussels-led; Lemsip is Slough-led. Filter LinkedIn searches by location to match the right brand.

04Decision tree · what happens after the first call

From discovery to signed LOI in 12 weeks · the 8-stage funnel applied to Reckitt.

WK
STEP
GATE
WK 0
Stage 02 · Open. Intro email sent. Follow-up cadence engaged. Target: response within 5 business days.
Open
WK 1–2
Stage 03 · Discover. 30-min discovery call. Demo studio.vantage-otc.com (via temp Cloudflare Access policy for reviewer email · 14-day session). Walk concept · launch plan · category brief.
Continue
WK 3–5
Stage 04 · Diagnose. 2nd call with brand team(s). Tailored conversation per brand. Discuss specific category fit, internal champion, commercial timing.
Continue
WK 6–7
Stage 05 · Propose. Formal proposal · pricing · embed mockup demo · sponsor-pack terms. Decision: do we have a real interest? Yes/no by end of WK 7.
Critical gate
WK 8–11
Stage 06 · Negotiate. Contract redlines · exclusivity language · per-market scope · MSA terms · legal review. Possible scope expansion (e.g., Nurofen all-product portfolio).
Continue
WK 12
Stage 07 · Sign. LOI signed by 13 August latest. Final contract within 4 weeks. October 27 launch confirmed.
LOI · GO
WK 13–14
Stage 08 · Activate. Brand-asset exchange · embed instance built · co-branded widget reviewed by Reckitt brand teams · QA · go-live ready.
Launch ready
RISK · CRITICAL PATH SLIPPAGE
If WK 0 doesn't happen this week (by 29 May), the math compresses. Every week of delay reduces the LOI buffer at WK 12 by ~1 week. By WK 4, the October launch starts requiring Reckitt to skip the proposal stage and accept a "good enough" agreement — which reduces both deal value and renewal probability for 2027.
Bottom line: first email out by Wednesday 27 May is the right operational target.
VANTAGE-OTC LABS · SPONSOR PITCH · RECKITT MASTER AGREEMENT
Draft v1 · 2026-05-22 · ready for review · do not send outside Cloudflare Access without founder sign-off
Reckitt · Strepsils · Lemsip · Nurofen · Gaviscon are trademarks of Reckitt Benckiser Group plc · referenced for sponsorship-discussion purposes only · no arrangement implied or contracted